TELONERASE AS AN ADROGEN RECEPTOR-REGULATED TARGET IN SELENIUM CHEMOPREVENTION OF PROSTATE CANCER

$110,007FY2008Department of DefenseDOD

Health Research, Inc., Rockville MD

Investigators